Thymoglobuline

Medicinal product

(Invented) name

Thymoglobuline

Active substance (s)

Triušių imunoglobulinas prieš žmogaus timocitus

Strength

25 mg

Pharmaceutical form

milteliai infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AA04, Antithymocyte immunoglobulin (rabbit)

Marketing authorisation holder

Sanofi B.V., Nyderlandai

Date of authorisation

2004-01-13

Date of renewal

2013-12-05

Documents

3459 Pakuotės lapelis 2023 09 01.docx

3459 Thymoglobuline RPP 2023 09 01.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Viename flakone yra	1 vnt.
Triušių imunoglobulinas prieš žmogaus timocitus	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
11042	15566	1015566	flakonas	N1		Receptinis	LT/1/04/3459/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2013-12-05	Perregistruotas
2004-01-13	Registruotas